Forty labor, healthcare and other advocacy groups are calling on President Biden to invoke the Defense Production Act to halt the shutdown of the largest U.S. generic drugs plant at the end of this month. One thousand five hundred people are on the verge of losing their jobs at Viatris’s Mylan Pharmaceuticals plant in West Virginia, which will start outsourcing its manufacturing to India. The groups say the move will leave the U.S. with virtually no domestic production of generic pharmaceuticals, threatening the supply chain for essential drugs.